Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 5 March, 2015 by The TZ Newswire Staff

Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February

Ariad Pharmaceuticals’ shares rocket to their highest levels since last Spring following a double-dose of positive news for shareholders. Find out whether this momentum can continue.

See also
- Next Article This Is the Worst Place to Save Money, but Many Do It Anyway
- Previous Article China lowers growth target, promises to open industries
Editorial Calender

March 2015

M T W T F S S

1

2 3 4 5 6 7 8

9 10 11 12 13 14 15

16 17 18 19 20 21 22

23 24 25 26 27 28 29

30 31

« Feb Apr »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 5 March, 2015 by The TZ Newswire Staff

Why Ariad Pharmaceuticals, Inc. Catapulted 26% Higher in February

See also

Editorial Calender

Recent Tags